Big Pharma Voluntary List Price Reductions Doubtful, Sen. Warren Says

None of the 10 large biopharmaceutical manufacturers contacted at the end of May by US Democratic senators said they have voluntarily lowered list prices since President Trump announced his drug pricing blueprint, Sen. Elizabeth Warren, D-Mass., said at a June 12 hearing.

“Zero out of 10 gave any indication that they plan to do so and in fact, one out of 10 said prices are going to go up later this year,” Warren added. Warren and Sen. Tina Smith, D-Minn., wrote to companies in late May after President Trump said publicly that some firms would be announcing “massive” price reductions in response to the Administration’s drug pricing blueprint